https://www.prnewswire.com/news-releases/fda-approval-of-amgens-uplizna-for-igg4-related-disease-opens-new-market-opportunity-in-rare-autoimmune-segment--delveinsight-302427346.html
/PRNewswire/ -- IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma cells in affected...
fda approvalamgenupliznarelateddisease